EUVIMEDEUVIMED entdecken
Crossref

Macrophages‐Cancer Membrane‐Encapsulated Metal−Organic Frameworks with Copper‐Depleting Moiety for Mitochondria‐Targeted Therapeutics

Weiqun Li, Mingjie Dong, Yingchun Li, Haifeng Dong iD

Advanced Healthcare Materials · 2023

DOI: 10.1002/adhm.202202986 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2023. Verfasst von Weiqun Li und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Science, Harbin Institute of Technology (Shenzhen), 518055, Shenzhen, China. Hauptthemen laut MEDLINE: Metal-Organic Frameworks, Neoplasms, Nanoparticles, MicroRNAs. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 25 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Shenzhen University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mitochondria‐targeted therapeutics are an attractive approach against energy‐dependent cancer. However, effective mitochondria organelle therapeutics agents are still highly desirable. Herein, a mitochondria‐targeted therapeutics platform, termed CDM@MUiO‐DP@MCHM, consisting of macrophages‐cancer hybrid membrane (MCHM) encapsulated MUiO‐66 metal−organic frameworks (MOFs) is reported, which is loaded with microRNA (miRNA) biomarker detection probe (DP) for cancer diagnosis and copper‐depleting moiety (CDM) for mitochondrial copper depletion to suppress cancer growth. Using nude mice bearing MCF‐7 as model, after injecting intravenously via the caudal vein of mice, the encapsulation of MCHM can not only greatly enhance the cancer homing‐targeting ability of the nanoparticles (NPs) but also endows the NPs the immune escape capacity to extend the circulation time. The miRNA‐21 biomarker can be detected by the fluorescence signal for diagnosis, while the CDM induced energy deficiency and compromised mitochondria membrane potential, leading to apoptosis of the cancer cell. The good performance of CDM@MUiO‐DP@MCHM suggest the great potential mitochondria organelle therapeutics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Metal-Organic FrameworksNeoplasmsNanoparticlesMicroRNAsAnimalsMiceCopperMice, NudeMitochondria

Stichwörter der Autor:innen

chemodynamic therapyhybrid membranesimmune escapesmiRNA-21 detectionsmitochondria-targeting

Substanzen

Metal-Organic FrameworksCopperMicroRNAs

Autor:innen und Institutionen

  • School of Science, Harbin Institute of Technology (Shenzhen), 518055, Shenzhen, China.
  • School of Chemistry and Chemical Engineering, Harbin Institute of Technology, 150001, Harbin, China.
  • Marshall Laboratory of Biomedical Engineering, Precision Medicine and Health Research Institute, School of Biomedical Engineering, Health Science Center, Shenzhen University, 518060, Shenzhen, China.

ORCID-Profile: Haifeng Dong

Förderung

  • National Natural Science Foundation of China
  • Shenzhen University

Zitieren

APA

Li, W., Dong, M., Li, Y., & Dong, H. (2023). Macrophages‐Cancer Membrane‐Encapsulated Metal−Organic Frameworks with Copper‐Depleting Moiety for Mitochondria‐Targeted Therapeutics. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202202986

Vancouver

Li W, Dong M, Li Y, Dong H. Macrophages‐Cancer Membrane‐Encapsulated Metal−Organic Frameworks with Copper‐Depleting Moiety for Mitochondria‐Targeted Therapeutics. Advanced Healthcare Materials. 2023. doi:10.1002/adhm.202202986

BibTeX
@article{Li2023,
  author = {Li, Weiqun and Dong, Mingjie and Li, Yingchun and Dong, Haifeng},
  title = {Macrophages‐Cancer Membrane‐Encapsulated Metal−Organic Frameworks with Copper‐Depleting Moiety for Mitochondria‐Targeted Therapeutics},
  journal = {Advanced Healthcare Materials},
  year = {2023},
  doi = {10.1002/adhm.202202986}
}
Kostenlos starten →